We are live on ! Find out more
VBIV

VBI Vaccines, Inc. New Common Stock (Canada)
VBIV

Delisted

VBIV was delisted on the 7th of August, 2024.

Back to rankings

14 hedge funds and large institutions have $25.6M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

17% more funds holding

Funds holding: 12 → 14 (+2)

14% more capital invested

Capital invested by funds: $22.4M → $25.6M (+$3.16M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
3
Increased
3
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$1.72M
2
RI
RTW Investments
New York
+$1.72M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$167K
4
Goldman Sachs
Goldman Sachs
New York
+$61.3K
5
Morgan Stanley
Morgan Stanley
New York
+$2.54K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$4.12K

VBIV Hedge Fund Activity: Q3 2015 in Review

14 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) for Q3 2015, worth a combined $25.6M — up 14% from $22.4M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new VBIV positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Perceptive Advisors, adding an estimated $1.72M. The largest seller was UBS Group, cutting an estimated $4.12K.

  • 14 institutional investors held VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) as of Q3 2015, up from 12 in Q2 2015.
  • Funds reported $25.6M of VBI Vaccines, Inc. New Common Stock (Canada) stock for Q3 2015, up 14% quarter-over-quarter.
  • 3 funds opened new VBI Vaccines, Inc. New Common Stock (Canada) positions in Q3 2015 and 1 closed out, a net change of +2 holders.
  • The largest VBI Vaccines, Inc. New Common Stock (Canada) buyer in Q3 2015 was Perceptive Advisors, an estimated $1.72M added.
  • The largest VBI Vaccines, Inc. New Common Stock (Canada) seller in Q3 2015 was UBS Group, an estimated $4.12K sold.

Based on aggregated 13F filings for Q3 2015.